This session includes a required evaluation

"Developing glial adenosine metabolism as a novel therapeutic target in Parkinson’s disease"

Dr. Abby Olsen, MD, PhD
Assistant Professor for Neurology
University of Pittsburgh and UPMC
 Zoom only :
https://partners.zoom.us/j/82375385585
CME code: pending

Learning objectives:

1) Learn how a novel Drosophila model of Parkinson’s disease can be used to identify glial-based therapeutic targets

2) Understand how glial adenosine metabolism represents a new therapeutic target for Parkinson’s disease

3) Understand the function of the adenylate kinase 1 (Ak1) gene

Course Directors:
Gary Ho, MD, PhD & Richard Krolewski, MD, PhD & Barbara Kelly Changizi, MD

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credit^TM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.